Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)
Clinical trial NCT04930562 · COMPLETED
Trial details
- NCT number
- NCT04930562
- Sponsor
- BioNova Pharmaceuticals (Shanghai) LTD.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-27
- Primary completion
- 2022-06-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.